Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial

被引：0
|
作者：
Atefeh Zandifar
Maryam Panahi
Rahim Badrfam
Mostafa Qorbani
机构：
[1] Alborz University of Medical Sciences,Social Determinants of Health Research Center
[2] Imam Hossein Hospital,Department of Psychiatry
[3] Alborz University of Medical Sciences,Faculty of Medicine
[4] Alborz University of Medical Sciences,Non
[5] Alborz University of Medical Sciences,communicable Diseases Research Center
[6] Tehran University of Medical Sciences,Chronic Diseases Research Center, Endocrinology and Metabolism Research Institute
来源：
BMC Psychiatry | / 24卷
关键词：
Empagliflozin; Citalopram; Major depressive disorder; Neuromodulating; Anti-inflammatory;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zajecka, John
    Schatzberg, Alan
    Stahl, Stephen
    Shah, Amy
    Caputo, Angelika
    Post, Anke
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 135 - 144
  • [32] Pioglitazone as an adjunct to citalopram for moderate to severe major depressive disorder : Randomized double blind placebo-controlled trial
    Modabbernia, A.
    Sepanjnia, K.
    Akhondzadeh, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 151 - 151
  • [33] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
  • [34] L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial
    Araminia, Behin
    Shalbafan, Mohammadreza
    Mortezaei, Amirhosein
    Shirazi, Elham
    Ghaffari, Salomeh
    Sahebolzamani, Erfan
    Mortazavi, Seyyed Hosein
    Shariati, Behnam
    Ardebili, Mehrdad Eftekhar
    Aqamolaei, Ali
    Naderi, Sina
    Akhondzadeh, Shahin
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 267 : 131 - 136
  • [35] A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder
    Garakani, Amir
    Martinez, Jose M.
    Marcus, Sue
    Weaver, James
    Rickels, Karl
    Fava, Maurizio
    Hirschowitz, Jack
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (05) : 269 - 275
  • [36] A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder
    Septien-Velez, Lucia
    Pitrosky, Bruno
    Padmanabhan, Sudharshan Krishna
    Germain, Jean-Michel
    Tourian, Karen A.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (06) : 338 - 347
  • [37] A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder
    Brown, E. Sherwood
    Sayed, Nasreen
    Van Enkevort, Erin
    Kulikova, Alexandra
    Nakamura, Alyson
    Khan, David A.
    Ivleva, Elena I.
    Sunderajan, Prabha
    Bender, Bruce G.
    Holmes, Traci
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1604 - 1612
  • [38] Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
    Karbalaee, Monire
    Jameie, Melika
    Amanollahi, Mobina
    TaghaviZanjani, Fateme
    Parsaei, Mohammadamin
    Basti, Fatemeh A.
    Mokhtari, Saba
    Moradi, Kamyar
    Akhondzadeh, Shahin
    SCHIZOPHRENIA RESEARCH, 2023, 254 : 92 - 98
  • [39] Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: A randomized, double-blind, placebo-controlled, pilot clinical trial
    Talaei, Ali
    Moghadam, Maryam Hassanpour
    Tabassi, Sayyed Abolghasem Sajadi
    Mohajeri, Seyed Ahmad
    JOURNAL OF AFFECTIVE DISORDERS, 2015, 174 : 51 - 56
  • [40] Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
    Akhondzadeh, Shahin
    Tabatabaee, Maryam
    Amini, Homayoun
    Abhari, Seyed Ali Ahmadi
    Abbasi, Seyed Hesamedin
    Behnam, Behnaz
    SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 179 - 185
12345